Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells

Autor:	Wedel, Steffen1, Hudak, Lukasz1, Seibel, Jens-Michael1, Juengel, Eva1, Tsaur, Igor1, Haferkamp, Axel1, Blaheta, Roman A. Blaheta@em.uni-frankfurt.de
Zdroj:	Cancer Letters. Feb2011, Vol. 301 Issue 1, p17-28. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect